The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AMARIN CORP PLC | SPONSORED ADR | 023111404 | 23,352,227 | 1,673,395 | SH | SOLE | 1,673,395 | 0 | 0 | |||
| BIOHAVEN LTD | COM | G1110E107 | 5,793,847 | 513,184 | SH | SOLE | 513,184 | 0 | 0 | |||
| CYTOKINETICS INC | COM NEW | 23282W605 | 25,184,524 | 396,357 | SH | SOLE | 396,357 | 0 | 0 | |||
| INNOVIVA INC | COM | 45781M101 | 56,292,280 | 2,816,022 | SH | SOLE | 2,816,022 | 0 | 0 | |||
| IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 53,648,496 | 15,919,435 | SH | SOLE | 15,919,435 | 0 | 0 | |||
| LANTHEUS HLDGS INC | COM | 516544103 | 12,075,498 | 181,450 | SH | SOLE | 181,450 | 0 | 0 | |||
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 42,995,906 | 303,151 | SH | SOLE | 303,151 | 0 | 0 | |||
| REGENERON PHARMACEUTICALS | COM | 75886F107 | 3,234,135 | 4,190 | SH | SOLE | 4,190 | 0 | 0 | |||
| VOR BIOPHARMA INC | COM NEW | 929033207 | 332,219 | 25,399 | SH | SOLE | 25,399 | 0 | 0 | |||